Open original FDA record ↗Recall record
- FDA identifier
- Z-0814-2022
- Company in FDA record
- Cytocell Ltd.
- FDA record creation date
- Mar 21, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class III
Reason stated in the source
May show unexpected locus specific signals in addition to those at 14q32.
Source facts
- Action
- Cytocell issued Urgent Medical Device Recall letter (VC/2022/005) to Distributor/End User via email on 2/4/22 . Letter states reason for recall, health risk and action to take: Immediately examine your inventory and quarantine all product subject to recall. Cytocell requests that you destroy the remaining inventory. We also suggest that laboratories undertake a review of the results obtained with the affected devices and check that signal patterns were not misinterpreted as a result of any additional locus specific signals at 9q34. Please complete and return the enclosed response form as soon as possible. If you have any questions, contact Cytocell on Tel: +44 (0)1223 294048, Fax +44(0)1223 294986 or vigilance@ogt.com.
- Initiated
- 2022-02-04
- Root cause
- Under Investigation by firm
- Terminated
- 2024-11-06
- Distribution
- MN
- Recall number
- Z-0814-2022
- Recall status
- Terminated
- CDRH record ID
- 192167
- FDA record created
- 2022-03-21
- Recall event number
- 89669